Atypical fibroxanthoma/malignant fibrous histiocytoma

Dermatologic Therapy

Volumn 21, Issue 6, 2008, Pages 424-427

  Marcet, Steven ^a,b  

^a Newnan Dermatology   (United States)

^b Newnan Dermatology   (Georgia)

Author keywords

Atypical fibroxanthoma; Malignant fibrous histiocytoma; Mohs micrographic surgery

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CHEMOSURGERY; DIFFERENTIAL DIAGNOSIS; FIBROXANTHOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MELANOMA; METASTASIS; NERVE SHEATH TUMOR; RHABDOMYOSARCOMA; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA;

HEAD AND NECK NEOPLASMS; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 57449085346     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2008.00241.x     Document Type: Article

References (26)

1. Fretzin DF, Helwig EB. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973 : 31 : 1541 1552.
2. Davis JL, Randle HW, Zalla MJ, Roenigk RK, Brodland DG. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg 1997 : 23 : 105 110.
3. Dei Tos AP, Maestro R, Doglioni C, et al. Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 1994 : 145 : 11 17.
4. Dilek FH, Akpolat N, Metin A, Ugras S. Atypical fibroxanthoma of the skin and the lower lip in xeroderma pigmentosum. Br J Dermatol 2000 : 143 : 618 620.
5. Shao L, Newell B, Quintanilla N. Atypical fibroxanthoma and squamous cell carcinoma of the conjunctiva in xeroderma pigmentosum. Pediatr Dev Pathol 2007 : 10 : 149 152.
6. Nascimento AF, Chandrajit PR. Diagnosis and management of pleomorphic sarcomas in adults. J Surg Oncol 2008 : 97 : 330 339.
7. Al-Agha OM, Igbokwe AA. Malignant fibrous histiocytoma: between the past and the present. Arch Path Lab Med 2008 : 132 : 1030 1035.
8. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors, 5th edn. Philadelphia, PA : Mosby Elsevier, 2008.
9. Mckee PH. Pathology of the Skin, 2nd edn. London : Mosby-Wolfe, 1996 : 16 : 31 32.
10. Murali R, Palfreeman S. Clear cell atypical fibroxanthoma - report of a case with review of the literature. J Cutan Pathol 2006 : 33 : 343 348.
11. Dettrick A, Strutton G. Atypical fibroxanthoma with perineural or intraneural invasion: report of two cases. J Cutan Pathol 2006 : 33 : 318 322.
12. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978 : 41 : 2250 2266.
13. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992 : 16 : 213 228.
14. Cooper JZ, Newman SR, Scott GA, Brown MD. Metastasizing atypical fibroxanthoma (cutaneous malignant histiocytoma): report of five cases. Dermatol Surg 2005 : 31 : 221 225.
15. de Feraudy S, Mar N, McCalmont TH. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol 2008 : 32 : 1111 1122.
16. Monteagudo C, Calduch L, Navarro S, Joan-Figueroa A, Llombart-Bosch A. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol 2002 : 117 : 126 131.
17. Hartel PH, Jackson J, Ducatman BS, Zhang P. CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker. J Cutan Pathol 2006 : 33 (Suppl. 2 24 28.
18. Mathew RA, Schlauder SM, Calder KB, Morgan MB. CD117 immunoreactivity in atypical fibroxanthoma. Am J Dermatopathol 2008 : 30 : 34 36.
19. Sakamoto A, Oda Y, Itakura E, et al. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma. Hum Pathol 2001 : 32 : 1225 1231.
20. Helwig EB, May D. Atypical fibroxanthoma of the skin with metastasis. Cancer 1986 : 57 : 368 376.
21. Giuffrida TJ, Kligora CJ, Goldstein GD. Localized cutaneous metastases from an atypical fibroxanthoma. Dermatol Surg 2004 : 30 : 1561 1564.
22. Peiper M, Zurakowski D, Knoefel WT, Izbicki JR. Malignant fibrous histiocytoma of the extremities and trunk: an institutional review. Surgery 2004 : 135 : 59 66.
23. Engellau J, Anderson H, Rydholm A, et al. Time dependence of prognostic factors for patients with soft tissue sarcoma. AScandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas. Cancer 2004 : 100 : 2233 2239.
24. Zalla MJ, Randle HW, Brodland DG, Davis JL, Roenigk RK. Mohs surgery vs wide excision for atypical fibroxanthoma: follow-up. Dermatol Surg 1997 : 23 : 1223 1224.
25. Huether MJ, Zitelli JA, Brodland DG. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 2001 : 44 : 656 659.
26. Seavolt M, McCall M. Atypical fibroxanthoma: review of the literature and summary of 13 patients treated with Mohs micrographic surgery. Dermatol Surg 2006 : 32 : 435 441.